[Federal Register Volume 63, Number 238 (Friday, December 11, 1998)]
[Notices]
[Page 68473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-32979]



[[Page 68473]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 13, 1998, Cauldron 
Inc., DBA Cauldron Process Chemistry, 383 Phoenixville Pike, Malvern, 
Pennsylvania 19355, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
amphetamine (1100), a basic class of controlled substance listed in 
Schedule II.
    The firm plans to bulk manufacture amphetamine for the purpose of 
performing bioequivalency studies.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuances of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than February 9, 1999.

    Dated: December 2, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-32979 Filed 12-10-98; 8:45 am]
BILLING CODE 4410-09-M